Trials / Not Yet Recruiting
Not Yet RecruitingNCT06729320
A Randomized Controlled, Open, Single-center Clinical Study Evaluating the Efficacy and Safety of Umbilical Cord Blood Mononuclear Cells in Patients with Refractory Immune Effector Cell-related Hemocytopenia
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Beijing GoBroad Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to evaluate the safety and efficacy of umbilical cord blood mononuclear cell in the treatment of refractory immune effector cell-related hemocytopenia by observing the efficacy related factors and adverse reactions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Umbilical cord blood mononuclear cells | Intravenous infusion of UCB-MNCs (3×10\^8/ time, once a week, four times in total) |
| COMBINATION_PRODUCT | Conventional hematopoietic recovery therapy | Including but not limited to G-CSF, TPO, TPO receptor agonists, transfusions of red blood cells, platelets, etc. |
Timeline
- Start date
- 2024-12-01
- Primary completion
- 2025-06-01
- Completion
- 2025-12-01
- First posted
- 2024-12-11
- Last updated
- 2024-12-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06729320. Inclusion in this directory is not an endorsement.